Nomura Holdings Inc Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

Nomura Holdings Inc

  • $41.1 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$144.95 - $152.29 $62.1 Million - $65.2 Million
428,200 New
428,200 $63 Million
Q1 2022

May 18, 2022
SELL
$110.08 - $142.92 $4.28 Million - $5.56 Million
-38,900 Reduced 49.49%
39,700 $4.64 Million
Q4 2021

Feb 14, 2022
BUY
$99.73 - $148.48 $7.84 Million - $11.7 Million
78,600 New
78,600 $10.6 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email